![Amir Sherman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Amir Sherman
Nessuna posizione attualmente
Profilo
Dr. Amir Sherman is a Manager-Pre Clinical Research at CorAssist Cardiovascular Ltd.
He received his doctorate degree from The Hebrew University of Jerusalem.
Precedenti posizioni note di Amir Sherman
Società | Posizione | Fine |
---|---|---|
CorAssist Cardiovascular Ltd.
![]() CorAssist Cardiovascular Ltd. Medical SpecialtiesHealth Technology CorAssist Cardiovascular Ltd. develops therapeutic products for treating diastolic heart failure. Its proprietary technology enables the implantation of a device that directly improves cardiac diastolic function. The firm’s product, the ImCardia, is an elastic self-expanding device that is attached to the external left ventricular surface, through a simple off-pump closed heart procedure. The company was founded by Yair Feld, Yotam Reisner and Shay Dubi in 2003 and is headquartered in Haifa, Israel. | Corporate Officer/Principal | - |
Formazione di Amir Sherman
The Hebrew University of Jerusalem | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
CorAssist Cardiovascular Ltd.
![]() CorAssist Cardiovascular Ltd. Medical SpecialtiesHealth Technology CorAssist Cardiovascular Ltd. develops therapeutic products for treating diastolic heart failure. Its proprietary technology enables the implantation of a device that directly improves cardiac diastolic function. The firm’s product, the ImCardia, is an elastic self-expanding device that is attached to the external left ventricular surface, through a simple off-pump closed heart procedure. The company was founded by Yair Feld, Yotam Reisner and Shay Dubi in 2003 and is headquartered in Haifa, Israel. | Health Technology |
- Borsa valori
- Insiders
- Amir Sherman